搜尋結果
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 2 日前Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term ...
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 2 日前In a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some ...
Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks
Bloomberg· 18 小時前Have a confidential tip for our reporters? A Bristol Myers Squibb Co. lung cancer treatment ...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 6 日前Pembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters· 2 日前, opens new tab said it expects its cancer drug Lorbrena to top $1 billion in annual sales by ...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival ...
Reuters· 2 日前, opens new tab Trodelvy failed to improve survival for patients with advanced bladder cancer a ...
Valar Labs debuts AI-powered cancer care prediction tool and secures $22M
TechCrunch· 3 日前Putting AI to work in the healthcare industry is a tricky business; it’s even more so in ...
U.K. Skin Cancer Cases Predicted To Hit Record Highs This Year
Forbes· 6 日前Rates of melanoma skin cancer are higher than ever in the U.K., having risen by almost ...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
Reuters· 9 小時前A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac ...
Pharma Billionaire's Fortune More Than Doubles In A Day On Cancer Drug Trial News
Forbes· 2 日前Shares of biotech firm Summit Therapeutics more than tripled on Thursday following good news ...